LIQUIDIA

Serial Number 99158233
630

Registration Progress

Application Filed
Apr 28, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

LIQUIDIA

Basic Information

Serial Number
99158233
Filing Date
April 28, 2025
Drawing Code
0

Status Summary

Current Status
Active
Status Code
630
Status Date
Apr 28, 2025
Application
Pending
Classes
005 010

Rights Holder

Liquidia Technologies, Inc.

03
Address
419 Davis Drive, Suite 100
Morrisville, NC 27560

Ownership History

Liquidia Technologies, Inc.

Original Applicant
03
Morrisville, NC

Legal Representation

Attorney
Devon E. White

Application History

50 events
Date Code Type Description Documents
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Jun 17, 2025 IUAF S USE AMENDMENT FILED Loading...
Apr 28, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...

Detailed Classifications

Class 005
Pharmaceuticals and natural remedy preparations for the treatment of respiratory diseases and for systemic delivery via inhalation; Medicinal preparations and substances for the treatment of respiratory diseases and for systemic delivery via inhalation; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of pulmonary hypertension; Pharmaceuticals for treatment of respiratory diseases, namely, capsules comprised of microparticles and nanoparticles, comprised of polymers, excipients, therapeutics, and biologics sold as a kit with inhaler
First Use Anywhere: Jun 2, 2025
First Use in Commerce: Jun 2, 2025
Class 010
Inhalers for medical use; Nebulizers for medical purposes; Instruments and apparatus provided empty used for the inhalation of pharmaceuticals; Medical apparatus for facilitating the inhalation of pharmaceutical preparations
First Use Anywhere: Jun 2, 2025
First Use in Commerce: Jun 2, 2025

Additional Information

Design Mark
The mark consists of a circle containing a hexagon and another circle. Three lines appear through all three shapes. The wording "LIQUIDIA" appears to the right of the design.

Classification

International Classes
005 010